tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Karen Koski, 6 are a HOLD (46.15%), 1 are a SELL (7.69%), 6 are a BUY (46.15%).
Analyst Karen Koski, carries an average stock price target met ratio of 88.89% that have a potential upside of 48.9% achieved within 249 days.
Karen Koski’s has documented 20 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on AXDX, Accelerate Diagnostics at 08-Oct-2020.
Analyst best performing recommendations are on AXDX (ACCELERATE DIAGNOSTICS).
The best stock recommendation documented was for AXDX (ACCELERATE DIAGNOSTICS) at 8/9/2016. The price target of $260 was fulfilled within 36 days with a profit of $40 (18.18%) receiving and performance score of 5.05.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$5
$3.92 (362.96%)
$3
1 years 2 months 27 days ago
(30-Jul-2024)
6/6 (100%)
$0.11 (2.25%)
16
Hold
2 years 2 months 12 days ago
(15-Aug-2023)
3/4 (75%)
$-3.75 (-34.88%)
38
Hold
$7500
3 years 3 months 20 days ago
(07-Jul-2022)
3/5 (60%)
$3649 (94.75%)
390
Buy
$15000
4 years 11 months 22 days ago
(05-Nov-2020)
1/1 (100%)
$7050 (88.68%)
177
Hold
$200
$194.55 (3569.72%)
$200
8 years 5 months 20 days ago
(08-May-2017)
2/3 (66.67%)
$64.67 (8.94%)
172
What Year was the first public recommendation made by Karen Koski?
